ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,753,052 | +30.3% | 219,653 | +20.8% | 0.00% | 0.0% |
| Q2 2023 | $9,788,071 | +136.6% | 181,833 | +74.6% | 0.00% | – |
| Q1 2023 | $4,136,480 | +1.6% | 104,141 | +2.9% | 0.00% | – |
| Q4 2022 | $4,071,759 | +4.8% | 101,212 | -16.3% | 0.00% | -100.0% |
| Q3 2022 | $3,884,000 | +13.3% | 120,857 | +4.6% | 0.00% | – |
| Q2 2022 | $3,429,000 | +163.8% | 115,534 | +149.8% | 0.00% | – |
| Q1 2022 | $1,300,000 | -34.4% | 46,254 | +7.6% | 0.00% | – |
| Q4 2021 | $1,981,000 | -37.7% | 43,002 | -55.6% | 0.00% | – |
| Q3 2021 | $3,181,000 | -14.7% | 96,942 | -8.9% | 0.00% | – |
| Q2 2021 | $3,730,000 | -5.1% | 106,418 | -2.2% | 0.00% | -100.0% |
| Q1 2021 | $3,932,000 | -15.2% | 108,778 | -31.8% | 0.00% | 0.0% |
| Q4 2020 | $4,635,000 | +30.2% | 159,606 | +26.4% | 0.00% | 0.0% |
| Q3 2020 | $3,561,000 | -21.0% | 126,236 | -9.5% | 0.00% | 0.0% |
| Q2 2020 | $4,510,000 | +343.0% | 139,414 | +458.0% | 0.00% | – |
| Q1 2020 | $1,018,000 | -64.4% | 24,984 | -46.1% | 0.00% | -100.0% |
| Q4 2019 | $2,861,000 | +20.3% | 46,386 | +42.2% | 0.00% | 0.0% |
| Q3 2019 | $2,378,000 | -26.3% | 32,625 | -16.9% | 0.00% | 0.0% |
| Q2 2019 | $3,226,000 | +657.3% | 39,244 | +550.2% | 0.00% | – |
| Q1 2019 | $426,000 | -35.1% | 6,036 | -58.6% | 0.00% | – |
| Q4 2018 | $656,000 | -24.1% | 14,571 | -4.5% | 0.00% | – |
| Q3 2018 | $864,000 | -77.2% | 15,264 | -73.1% | 0.00% | -100.0% |
| Q2 2018 | $3,786,000 | +171.4% | 56,668 | +136.6% | 0.00% | – |
| Q1 2018 | $1,395,000 | -46.3% | 23,953 | -40.5% | 0.00% | -100.0% |
| Q4 2017 | $2,597,000 | +0.7% | 40,289 | -18.0% | 0.00% | 0.0% |
| Q3 2017 | $2,580,000 | -27.9% | 49,140 | -35.8% | 0.00% | 0.0% |
| Q2 2017 | $3,579,000 | +118.0% | 76,507 | +130.8% | 0.00% | – |
| Q1 2017 | $1,642,000 | -53.1% | 33,142 | -42.7% | 0.00% | -100.0% |
| Q4 2016 | $3,504,000 | +3.6% | 57,792 | +13.4% | 0.00% | 0.0% |
| Q3 2016 | $3,382,000 | +1821.6% | 50,981 | +1524.1% | 0.00% | – |
| Q2 2016 | $176,000 | -81.3% | 3,139 | -88.7% | 0.00% | – |
| Q1 2016 | $939,000 | +168.3% | 27,897 | +259.7% | 0.00% | – |
| Q4 2015 | $350,000 | -54.8% | 7,755 | -60.5% | 0.00% | – |
| Q3 2015 | $775,000 | -26.6% | 19,613 | +15.3% | 0.00% | – |
| Q2 2015 | $1,056,000 | -78.1% | 17,005 | -78.0% | 0.00% | -100.0% |
| Q1 2015 | $4,832,000 | -16.0% | 77,236 | -24.3% | 0.00% | 0.0% |
| Q4 2014 | $5,751,000 | +627.1% | 101,980 | +264.5% | 0.00% | – |
| Q3 2014 | $791,000 | -82.1% | 27,981 | -78.2% | 0.00% | -100.0% |
| Q2 2014 | $4,417,000 | +164.5% | 128,257 | +140.7% | 0.00% | +100.0% |
| Q1 2014 | $1,670,000 | +228.1% | 53,291 | +110.5% | 0.00% | – |
| Q4 2013 | $509,000 | – | 25,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |